Eli Lilly received FDA approval for its tirzepatide-based GLP-1 products, Mounjaro for diabetes and Zepbound for weight loss in May 2022 and November 2023, respectively
Structure modification and delivery system Considering the inherent physicochemical properties of NADs, the critical issue for their application is whether they can reach the target site and exert the expected therapeutic effects
To ensure product quality, strict tests should be conducted on the hardness, disintegration time limit and content uniformity of the tablets during the formulation process
107.Maron F., Mathiron D., Pilard S., Lemaire-Hurtel A.-S., Dubaele J.-M., Djedaini-Pilard F
Encapsulated vitamin stability through liposomal encapsulation maintains integrity, critical in nutraceutical production
H.ZhengM